CV Sciences (CVSI) Return on Capital Employed Growth (3y) (2014 - 2026)
CV Sciences (CVSI) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | 1,902.00 |
| 10 | CV Sciences | 4.11 Mn | 3.80 Mn | 1.56 Mn | -5,543.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,543.00 |
| Dec 31, 2025 | 103,862.00 |
| Sep 30, 2025 | 66,247.00 |
| Jun 30, 2025 | 40,145.00 |
| Mar 31, 2025 | 36,413.00 |
| Dec 31, 2024 | 40,014.00 |
| Sep 30, 2024 | 30,137.00 |
| Jun 30, 2024 | 3,543.00 |
| Mar 31, 2024 | 2,429.00 |
| Dec 31, 2023 | 21,358.00 |
| Sep 30, 2023 | 12,672.00 |
| Jun 30, 2023 | 8,931.00 |
| Mar 31, 2023 | 4,242.00 |
| Dec 31, 2022 | -102,075.00 |
| Sep 30, 2022 | -68,428.00 |
| Jun 30, 2022 | -44,813.00 |
| Mar 31, 2022 | -42,492.00 |
| Dec 31, 2021 | -32,391.00 |
| Sep 30, 2021 | -17,157.00 |
| Jun 30, 2021 | -14,747.00 |